Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol

Endocrine-Related Cancer

Volumn 15, Issue 4, 2008, Pages 1025-1034

  Louiset, E ^a   Isvi, K ^b   Gasc, J M ^c   Duparc, C ^a   Cauliez, B ^b   Laquerriere A ^b   Kuhn, J M ^a,b   Lefebvre, Herve ^a,b,d  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; HYDROCORTISONE; HYPERTENSIVE FACTOR; MESSENGER RNA; MITOTANE; RENIN; SEROTONIN; SEROTONIN 7 RECEPTOR; SPIRONOLACTONE; ANGIOTENSIN II; CORTICOTROPIN; HORMONE; PHENOL DERIVATIVE; SEROTONIN RECEPTOR; SULFONAMIDE; VASOCONSTRICTOR AGENT;

ADRENAL CORTEX CARCINOMA; ADRENALECTOMY; ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER CELL CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CUSHING SYNDROME; DEATH; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROCORTISONE RELEASE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; IN VITRO STUDY; MAST CELL; PANCYTOPENIA; PLASMA RENIN ACTIVITY; PROTEIN EXPRESSION; RENIN RELEASE; SHOCK; TOXIC CYTOLYTIC HEPATITIS; ADRENAL CORTEX TUMOR; DRUG EFFECT; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; TUMOR CELL CULTURE;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADRENOCORTICOTROPIC HORMONE; ANGIOTENSIN II; CUSHING SYNDROME; FEMALE; HORMONES; HUMANS; HYDROCORTISONE; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MAST CELLS; MIDDLE AGED; PHENOLS; RECEPTORS, SEROTONIN; RENIN; SEROTONIN; SULFONAMIDES; TUMOR CELLS, CULTURED; VASOCONSTRICTOR AGENTS;

EID: 58249112347     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0085     Document Type: Article

References (30)

1. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, Emy P, Bertagna X, Kuhn JM, Vaudry H et al. 2005 In vivo and in vitro screening for illegitimate receptors in ACTH-independent macronodular adrenal hyperplasia (AIMAH) causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. Journal of Clinical Endocrinology and Metabolism 90 1302-1310.
2. Beuschlein F, Fassnacht M, Klink A, Allolio B & Reincke M 2001 ACTH-receptor expression, regulation and role in adrenocortial tumor formation. European Journal of Endocrinology 144 199-206.
3. 4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular hyperplasia causing Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 88 248-254.
4. Contesse V, Lefebvre H, Lenglet S, Kuhn JM, Delarue C & Vaudry H 2000 Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells. Canadian Journal of Physiology and Pharmacology 78 967-983.
5. Contesse V, Reznik Y, Louiset E, Duparc C, Cartier D, Sicard F, Laquerriere A, Parmentier F, Kuhn JM, Vaudry H et al. 2005 Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studies. Journal of Clinical Endocrinology and Metabolism 90 2843-2850.
6. Gill GN, Ill CR & Simonian MH 1977 Angiotensin stimulation of bovine adrenocortical cell growth. PNAS 74 5569-5573.
7. Haak HR & Fleuren GJ 1995 Neuroendocrine differentiation of adrenocortical tumors. Cancer 75 860-864.
8. Iimura O, Shimamoto K, Hotta D, Nakata T, Mito T, Kumamoto Y, Dempo K, Ogihara T & Naruse K 1986 A case of adrenal tumor producing renin, aldosterone, and sex steroid hormones. Hypertension 8 951-956.
9. Juillerat-Jeanneret L, Celerier J, Chapuis Bernasconi C, Nguyen G, Wostl W, Maerki HP, Janzer RC, Corvol P & Gasc JM 2004 Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. British Journal of Cancer 90 1059-1068.
10. Lanfumey L & Hamon M 2004 5-HT1 receptors. Current Drug Targets. CNS and Neurological Disorders 3 1-10.
11. 4 receptor subtype. Neuroscience 47 999-1007.
12. Lefebvre H, Compagnon P, Contesse V, Delarue C, Thuillez C, Vaudry H & Kuhn JM 2001 Production and metabolism of serotonin (5-HT) by the human adrenal cortex: paracrine stimulation of aldosterone secretion by 5-HT. Journal of Clinical Endocrinology and Metabolism 86 5001-5007.
13. 7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 91 4578-4586.
14. Magiakou MA, Smyrnaki P & Chrousos GP 2006 Hypertension in Cushing's syndrome. Best Practice and Research. Clinical Endocrinology and Metabolism 20 467-482.
15. Messer CK, Kirschenbaum A, New MI, Unger P, Gabrilove JL & Levine AC 2007 Concomitant secretion of glucocorticoid, androgens, and mineralocorticoid by an adrenocortical carcinoma: case report and review of literature. Endocrine Practice 13 408-412.
16. Miettinen M 1992 Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy. Laboratory Investigation 66 169-174.
17. Mulrow PJ 1998 Renin-angiotensin system in the adrenal. Hormone and Metabolic Research 30 346-349.
18. Nelson DL 2004 5-HT5 receptors. Current Drug Targets. CNS and Neurological Disorders 3 53-58.
19. Niemann LK 2001 Cushing's syndrome. In: Endocrinology, edn 4, vol 2, pp 1695. Eds LJ DeGroot & JL Jameson, Philadelphia: WB Saunders Co.
20. Racz K, Pinet F, Gasc JM, Guyene TT & Corvol P 1992 Coexpression of renin, angiotensinogen, and their messenger ribonucleic acids in adrenal tissues. Journal of Clinical Endocrinology and Metabolism 75 730-737.
21. Rauly-Lestienne I, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A & Cussac D 2007 Differential profile of typical, atypical and third generation antipsychotics at human 5-HT(7a) receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties. Naunyn-Schmiedeberg's Archives of Pharmacology 376 93-105.
22. Sacerdote A, Weiss K, Tran T, Rokeya Noor B & McFarlane SI 2005 Hypertension in patients with Cushing's disease: pathophysiology, diagnosis, and management. Current Hypertension Reports 7 212-218.
23. Schutz S, Le Moullec JM, Corvol P & Gasc JM 1996 Early expression of all the components of the renin-angiotensin-system in human development. American Journal of Pathology 149 2067-2079.
24. Sibony M, Commo F, Callard P & Gasc JM 1995 Enhancement of mRNA in situ hybridization signal by microwave heating. Laboratory Investigation 73 586-591.
25. Stewart PM 1999 Cortisol as a mineralocorticoid in human disease. Journal of Steroid Biochemistry and Molecular Biology 69 403-408.
26. Thomas DR & Hagan JJ 2004 5-HT7 receptors. Current Drug Targets. CNS and Neurological Disorders 3 81-90.
27. Vallotton MB, Rossier MF & Capponi AM 1995 Potassium-angiotensin interplay in the regulation of aldosterone biosynthesis. Clinical Endocrinology 42 111-119.
28. Yamanaka K, Iitaka M, Inaba M, Morita T, Sasano, H & Katayama S 2000 A case of renin-producing adrenocortical cancer. Endocrine Journal 47 119-125.
29. Yoshiji H, Kuriyama S, Noguchi R & Fukui H 2004 Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy. Current Cancer Drug Targets 4 555-567.
30. Zhang PJ, Genega EM, Tomaszewski JE, Pasha TL & LiVolsi VA 2003 The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Modern Pathology 16 591-597.